• Home
  • Latest
  • Coins2Day 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconCOVID-19 vaccines

COVID-19 vaccines

Page 89 of 95
HealthRussia’s Sputnik V vaccine shows 91.6% efficacy rate, peer-reviewed findings say
By Yuliya Fedorinova, Stepan Kravchenko and BloombergFebruary 2, 2021
HealthJohnson & Johnson’s lower-immunity single-dose COVID vaccine might be just what the doctor ordered
By Kat EschnerFebruary 1, 2021
01 February 2021, Lower Saxony, Lingen: Senior citizen Maria Hesemann-Peters is vaccinated against the corona virus with the active ingredient from Biontech/Pfizer by emergency paramedic Bernd Rode from the DRK (German Red Cross) at the vaccination centre in the Emslandhallen.
HealthWhy Europe’s summer COVID vaccination target could still be on track
By David MeyerFebruary 1, 2021
HealthHow vaccine nationalism could extend the pandemic
By James Paton and BloombergJanuary 31, 2021
President Biden Delivers Remarks On His Racial Equity Agenda And Signs Executive Actions
PoliticsJoe Biden’s cabinet: What you need to know about the President’s key advisers and their top priorities
By Nicole GoodkindJanuary 31, 2021
Tom Richmond receives his AstraZeneca/Oxford University Covid-19 vaccine from Vaccinator Louise Chadwick at Acklam Road pharmacy on January 28, 2021 in Middlesbrough, England.
HealthWith supplies running low, Europe approves AstraZeneca’s COVID-19 vaccine for all adults
By Jeremy Kahn and David MeyerJanuary 29, 2021
HealthThe 3 major fixes broken health systems need, according to experts
By Erika FryJanuary 29, 2021
PoliticsJohnson & Johnson’s single-dose COVID-19 vaccine is 66% effective, lagging rivals
By The Associated PressJanuary 29, 2021
Pascal Soriot, chief executive officer of AstraZeneca Plc, listens during a Senate Finance Committee hearing on drug pricing on Capitol Hill in Washington, D.C., U.S., on Tuesday, Feb. 26, 2019.
HealthGermany may not use AstraZeneca’s vaccine for over-65s, as experts debate lack of data
By Jeremy Kahn and David MeyerJanuary 28, 2021
Valneva-Covid19 Vaccine
HealthFrance’s Valneva starts making COVID-19 vaccine in Scotland, ahead of trial results and approval
By David MeyerJanuary 28, 2021
HealthState-by-state COVID vaccine rates: Idaho and Missouri are in last place
By Erika Fry and Nicolas RappJanuary 27, 2021
COVID vaccine second shot, dose
HealthWhat to know about delaying second COVID vaccine shots as countries grapple with limited supplies
By John Lauerman, Jason Gale and BloombergJanuary 26, 2021
An NHS staff member prepares an AstraZeneca Covid-19 vaccination as over-eighty year olds receive their vaccinations on January 26, 2021 at Stithians Showground, near Truro, England.
HealthFurious at AstraZeneca, the EU plans export controls for COVID vaccines made on its home turf
By David MeyerJanuary 26, 2021
US-VIRUS-HEALTH-VACCINATION
HealthCEO who jumped the COVID vaccine line is out of a job
By BloombergJanuary 25, 2021
Pharmacist Josh Athwal (left) receives an injection of the Oxford/Astrazeneca coronavirus vaccine, administered by nurse Gurit Dhadday, at The Black Country Living Museum in Dudley.
HealthAstraZeneca is finding it hard to keep its COVID-19 vaccine promises
By David MeyerJanuary 25, 2021
1...
  • 87
  • 88
  • 89
  • 90
  • 91
...95
Most Popular
Success
In 2026, many employers are ditching merit-based pay bumps in favor of ‘peanut butter raises’An image of a popular article
By Emma BurleighFebruary 2, 2026
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House postAn image of a popular article
By Eleanor PringleFebruary 4, 2026
Investing
Tech stocks go into free fall as it dawns on traders that AI has the ability to cut revenues across the boardAn image of a popular article
By Jim EdwardsFebruary 4, 2026
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.